Correction to: Oncogene (2013) 32, 1530−1538; doi:10.1038/onc.2012.173; published online 14 May 2012
Since the online publication of this article the authors realised an error in the Materials and Methods Section. On p. 7, under 'Locked nucleic acids', the text reads: ‘The short LNA oligonucleotide sequence (anti-miR-10b), 5′-ThioMC6-D/GTGTAACACGTCTATACGCCCA-3′, directed against miRNA-10b and a mismatch scrambled sequence (scr-miR), 5′-ThioMC6-D/CACAAATTCGGTTCTACAGGGTA-3′, were synthesized by Exiqon Inc.’
The designation of the sequences is wrong. The sequence listed as anti-miR-10b is in fact the mismatch scrambled sequence and the mismatch scrambled sequence is in fact the anti-miR-10b sequence.
The text should read: ‘The short LNA oligonucleotide sequence (anti-miR-10b), 5′-ThioMC6-D/CACAAATTCGGTTCTACAGGGTA-3′, directed against miRNA-10b and a mismatch scrambled sequence (scr-miR), 5′-ThioMC6-D/GTGTAACACGTCTATACGCCCA-3′, were synthesized by Exiqon Inc.’
The authors apologise for any inconvenience caused by this error.
Additional information
The online version of the original article can be found at 10.1038/onc.2012.173
Rights and permissions
About this article
Cite this article
Yigit, M., Ghosh, S., Kumar, M. et al. Erratum: Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis. Oncogene 36, 2628 (2017). https://doi.org/10.1038/onc.2016.413
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2016.413
